DFTX Definium Therapeutics, Inc.

Fundamentals / CIK 0001813814 / USD

Definium Therapeutics, Inc. reported $1.07B in total assets and a net loss of $337.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DFTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$171.8MFY 2020 Net Income: -$33.94M2020FY 2021 Net Income: -$93.04M2021FY 2022 Net Income: -$56.80M2022FY 2023 Net Income: -$95.73M2023FY 2024 Net Income: -$108.7M2024FY 2025 Net Income: -$183.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $117.7M $65.30M $52.12M $36.17M $34.79M $18.63M
Total Operating Expenses $166.3M $103.9M $93.87M $66.33M $93.85M $33.03M
Operating Income -$166.3M -$103.9M -$93.87M -$66.33M -$93.85M -$33.03M
Interest Income $10.96M $11.56M $5.58M -- -- --
Interest Expense $5.48M $2.28M $920K -- -- --
Income Before Tax -$183.8M -$108.7M -$95.73M -$56.80M -$94.19M -$33.94M
Income Tax Expense $0 -- -- -- -$1.16M --
Net Income -$183.8M -$108.7M -$95.73M -$56.80M -$93.04M -$33.94M
Basic EPS -$2.06 -$1.54 -$2.44 -$1.84 -$51.00 -$1.95
Diluted EPS -$2.06 -$1.54 -$2.44 -$1.84 -$51.00 -$1.95
Basic Shares Outstanding 89.3M 70.5M 39.2M 30.9M 1.8M 17.7M
Diluted Shares Outstanding 89.3M 70.5M 39.2M 30.9M 1.8M 17.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $46.14M $48.66M $41.48M $33.52M $30.98M $29.81M $23.36M $21.76M
Total Operating Expenses $72.28M $75.08M $59.22M $47.58M $45.67M $40.90M $32.16M $32.46M
Operating Income -$72.28M -$75.08M -$59.22M -$47.58M -$45.67M -$40.90M -$32.16M -$32.46M
Interest Income $10.14M $3.59M $3.46M $3.49M $2.26M $2.77M $2.43M $3.28M
Interest Expense $1.15M $1.23M $1.25M $1.27M $1.27M $2.34M $602K $656K
Net Income -$50.96M -$159.0M -$77.10M -$50.44M -$67.27M -$42.74M -$23.35M -$34.74M
Basic EPS -$0.37 -$1.44 -$0.71 -- -$0.78 -$0.50 -$0.27 --
Diluted EPS -$0.46 -$1.44 -$0.71 -- -$0.78 -$0.50 -$0.35 --
Basic Shares Outstanding 135.9M 110.7M 108.8M -- 85.9M 85.3M 85.1M --
Diluted Shares Outstanding 137.3M 110.7M 108.8M -- 85.9M 85.3M 87.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $257.8M $273.7M $99.70M $142.1M $133.5M $80.09M
Short-Term Investments $153.8M $0 -- -- -- --
Cash & Short-Term Investments $411.6M $273.7M $99.70M $142.1M $133.5M $80.09M
Total Current Assets $419.3M $281.6M $103.9M $146.1M $137.2M $81.52M
Goodwill $19.92M $19.92M $19.92M $19.92M $19.92M $0
Intangible Assets -- $0 $527K $3.69M $6.87M --
Long-Term Investments -- $0 -- -- -- --
Other Non-Current Assets $862K $613K $224K $331K -- --
Total Non-Current Assets $20.78M $20.53M $20.67M $23.94M $26.79M $0
Total Assets $440.1M $302.2M $124.5M $170.0M $164.0M $81.52M
Accounts Payable $5.35M $2.01M $4.14M $2.11M $4.18M $2.02M
Total Current Liabilities $66.70M $38.85M $32.25M $17.89M $10.41M $3.01M
Long-Term Debt $40.58M $21.85M $14.13M -- -- --
Other Non-Current Liabilities $496K -- $32K $1.18M $1.93M --
Total Non-Current Liabilities $41.08M $21.85M $14.16M $1.18M $1.93M $2.64M
Total Liabilities $107.8M $60.70M $46.41M $19.08M $12.34M $5.65M
Total Debt (incl. Leases) $40.58M $21.85M $14.13M -- -- --
Common Stock -- $0 $0 -- -- --
Retained Earnings -$582.7M -$398.9M -$290.2M -$194.5M -$137.7M -$44.64M
Accumulated Other Comp. Income $1.08M $819K $343K $627K $1.05M $284K
Total Stockholders' Equity $332.3M $241.4M $78.13M $150.9M $151.7M $75.87M
Total Equity $332.3M $241.4M $78.13M $150.9M $151.7M $75.87M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $241.2M $655.3M $262.5M $257.8M $19.96M $33.39M $82.85M $273.7M
Short-Term Investments $805.7M $428.6M $110.9M $153.8M $189.1M $149.6M $129.6M $0
Cash & Short-Term Investments $1.05B $1.08B $373.4M $411.6M $209.1M $183.0M $212.4M $273.7M
Total Current Assets $1.05B $1.09B $380.6M $419.3M $215.8M $189.1M $221.7M $281.6M
Goodwill $19.92M $19.92M $19.92M $19.92M $19.92M $19.92M $19.92M $19.92M
Intangible Assets -- -- -- -- -- -- -- $0
Long-Term Investments -- -- -- -- -- $54.86M $33.10M $0
Other Non-Current Assets $2.61M $880K $812K $862K $1.15M $1.17M $606K $613K
Total Non-Current Assets $22.52M $20.80M $20.73M $20.78M $21.07M $75.95M $53.62M $20.53M
Total Assets $1.07B $1.11B $401.3M $440.1M $236.9M $265.1M $275.3M $302.2M
Accounts Payable $9.28M $6.96M $7.13M $5.35M $8.11M $4.22M $2.27M $2.01M
Total Current Liabilities $67.73M $157.2M $81.11M $66.70M $65.42M $37.96M $30.48M $38.85M
Long-Term Debt $36.66M $36.47M $40.77M $40.58M $40.38M $41.19M $22.04M $21.85M
Other Non-Current Liabilities $1.86M $549K $559K $496K $519K $543K -- --
Total Non-Current Liabilities $38.52M $37.02M $41.33M $41.08M $40.90M $41.73M $22.04M $21.85M
Total Liabilities $106.2M $194.2M $122.4M $107.8M $106.3M $79.69M $52.52M $60.70M
Total Debt (incl. Leases) $36.66M $36.47M $40.77M $40.58M $40.38M $41.79M $22.04M $21.85M
Common Stock -- -- -- -- -- -- -- $0
Retained Earnings -$869.7M -$818.8M -$659.8M -$582.7M -$532.2M -$465.0M -$422.2M -$398.9M
Accumulated Other Comp. Income -$829K $417K $824K $1.08M $1.00M $807K $802K $819K
Total Stockholders' Equity $968.0M $918.7M $278.8M $332.3M $130.6M $185.4M $222.8M $241.4M
Total Equity $968.0M $918.7M $278.8M $332.3M $130.6M $185.4M $222.8M $241.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$183.8M -$108.7M -$95.73M -$56.80M -$93.04M -$33.94M
Stock-Based Compensation $20.10M $16.91M $15.18M $13.71M $42.72M $7.41M
Change in Payables $3.34M -$2.13M $2.02M -$2.06M $1.28M $544K
Operating Cash Flow -$131.6M -$79.13M -$64.36M -$50.14M -$45.82M -$23.60M
Acquisitions, Net -- -- -- -- -$297K --
Purchases of Investments -$268.4M $0 -- -- -- --
Investing Cash Flow -$151.6M $0 -- -- -$297K --
Common Stock Issued $0 $984K $7.53M $42.30M $81.92M $71.99M
Financing Cash Flow $267.3M $253.2M $21.85M $59.05M $98.82M $96.70M
Net Change in Cash -$15.90M $174.0M -$42.44M $8.60M $53.45M $73.39M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$50.96M -$159.0M -$77.10M -$50.44M -$67.27M -$42.74M -$23.35M -$34.74M
Stock-Based Compensation $10.78M $9.64M $7.13M $5.60M $5.82M $5.25M $3.43M $3.95M
Change in Payables $2.31M -$162K $1.78M -$2.77M $3.90M $1.95M $258K -$139K
Operating Cash Flow -$52.98M -$52.78M -$42.63M -$42.98M -$29.57M -$29.60M -$29.42M -$25.35M
Purchases of Investments -$442.8M -$355.7M $0 -$6.02M -$26.59M -$73.29M -$162.5M $0
Investing Cash Flow -$372.8M -$316.7M $42.00M $34.98M $15.41M -$39.54M -$162.5M $0
Financing Cash Flow $11.66M $762.3M $5.31M $245.9M $749K $19.65M $1.00M $3.81M
Net Change in Cash -$414.1M $392.7M $4.68M $237.9M -$13.43M -$49.46M -$190.9M -$21.54M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -55.3% -45.0% -122.5% -37.6% -61.3% -44.7%
Return on Assets (ROA) -41.8% -36.0% -76.9% -33.4% -56.7% -41.6%
Current Ratio 6.29x 7.25x 3.22x 8.16x 13.18x 27.10x
Quick Ratio 6.17x 7.05x 3.09x 7.94x 12.83x 26.63x
Debt to Equity 0.12x 0.09x 0.18x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -34.9% -38.5% -85.2% -55.3% -128.7% -61.8% -34.8% -45.0%
Return on Assets (ROA) -31.4% -31.8% -59.2% -41.8% -71.0% -43.2% -28.2% -36.0%
Current Ratio 15.53x 6.95x 4.69x 6.29x 3.30x 4.98x 7.27x 7.25x
Quick Ratio 15.46x 6.89x 4.60x 6.17x 3.20x 4.82x 6.97x 7.05x
Debt to Equity 0.04x 0.04x 0.15x 0.12x 0.31x 0.23x 0.10x 0.09x
Source: SEC EDGAR CompanyFacts (CIK 0001813814) · from December 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:16 UTC · Open in terminal